Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nanobiotix S.A. ADR (NQ: NBTX ) 4.770 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nanobiotix S.A. ADR < Previous 1 2 3 4 5 6 7 8 9 Next > Voting Rights and Shares Capital of the Company August 08, 2024 From Nanobiotix S.A. Via GlobeNewswire Voting Rights and Shares Capital of the Company July 09, 2024 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024 June 12, 2024 From Nanobiotix S.A. Via GlobeNewswire Voting Rights and Shares Capital of the Company June 11, 2024 From Nanobiotix S.A. Via GlobeNewswire Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy June 02, 2024 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call May 28, 2024 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX to Present at the Jefferies Global Healthcare Conference May 23, 2024 From Nanobiotix S.A. Via GlobeNewswire Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 22, 2024 Via Benzinga NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update May 22, 2024 From Nanobiotix S.A. Via GlobeNewswire Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth May 21, 2024 From Nanobiotix S.A. Via GlobeNewswire Voting Rights and Shares Capital of the Company May 16, 2024 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024 May 15, 2024 Conference call and webcast scheduled on May 22, 2024, at 8:00 am EDT / 2:00 pm CEST From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer May 14, 2024 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results April 24, 2024 From Nanobiotix S.A. Via GlobeNewswire NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024 April 17, 2024 Conference call and webcast scheduled for Thursday, April 25, 2024, at 8:00 am EDT / 2:00 pm. CEST From Nanobiotix S.A. Via GlobeNewswire CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session April 11, 2024 U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday. Via Benzinga Topics Stocks Exposures US Equities Voting Rights and Shares Capital of the Company April 10, 2024 From Nanobiotix S.A. Via GlobeNewswire Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation April 02, 2024 From Nanobiotix S.A. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session March 18, 2024 Via Benzinga Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket March 18, 2024 Shares of Nuvei Corp (NASDAQ: NVEI) rose sharply in today’s pre-market trading following a report indicating the company is in buyout talks with Advent International. Nuvei shares jumped 14.1% to... Via Benzinga Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 18, 2024 Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday March 18, 2024 Pre-market stock movers are the perfect way to start the week as we dive into the biggest stories moving shares on Monday! Via InvestorPlace Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session March 18, 2024 U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining by around 100 points on Monday. Shares of Logitech International S.A. (NASDAQ: LOGI) fell in today’s pre-market... Via Benzinga Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 11, 2024 Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart... Via Benzinga Exposures Product Safety EQT, Genie Energy And Other Big Stocks Moving Lower On Monday March 11, 2024 U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday. Via Benzinga Topics Stocks Exposures US Equities Nanobiotix to Present at Upcoming Investor Conferences in March March 06, 2024 From Nanobiotix S.A. Via GlobeNewswire Voting Rights and Shares Capital of the Company February 13, 2024 From Nanobiotix S.A. Via GlobeNewswire Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference January 31, 2024 From Nanobiotix S.A. Via GlobeNewswire General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday January 30, 2024 U.S. stocks traded slightly lower, with the Dow Jones falling around 20 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study January 29, 2024 From Nanobiotix S.A. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.